**Dear Editor,**

The need for platelet concentrates (PCs) is currently growing while the use of packed red blood cells is on the decline. PCs that are stored at room temperature (20-24 °C) provide a bacterial growth condition and are regarded as the main cause of bacterially induced transfusion disorders.^[@ref1]^ Recently, the antibacterial effects of several agents have been evaluated in platelets.^[@ref1],[@ref2]^ Epsilon-Poly-L-lysine (ε-PLL) is a polypeptide composed of 27 to 33 identical L-lysine subunits, which was studied for the first time in Japan as an antimicrobial agent in PCs.^[@ref3]^

In the present study, PCs units were collected from healthy blood donors who visited the Blood Bank of Tehran (Iran) to determine the efficacy of the bactericidal activity of ε-PLL. Informed consent was obtained from all donors and the project was approved by the Research Ethics Committees of the Iranian blood transfusion organization.

The results indicated that the growth of *S. epidermis, Pseudomonas aerugenosa*, *E. coli*, and *S. aureus* in PCs was completely inhibited after 8 days of incubation with 100 µg/mL ε-PLL. There were no significant differences between the untreated controls and the PCs treated with ε-PLL in terms of the PCs quality variables ([table 1](#T1){ref-type="table"}). These findings are consistent with a previous report in Japan. In a study by Tanaka et al.,^[@ref3]^ ε-PLL was found to inhibit the growth of the bacterial contaminants *S. aureus, B. cereus*, and *K. oxytoca* in the concentrations of 200 and 50 µg/mL in the plasma and PAS-IIIM PCs, respectively, after 8 days of incubation. Moreover, they demonstrated that ε-PLL did not significantly affect the quality of the PCs except for increased CD62P expression. The results of a study by Liu et al.^[@ref4]^ also showed the combination of ε-polylysine and nisin has synergistic antimicrobial activity against E. coli, B. subtilis, and S. aureus. Samadi et al.^[@ref5]^ investigated the antimicrobial activities of magnesium oxide nanoparticles and ε-PLL against two major foodborne bacteria, *Escherichia coli* O157:H7 and Listeria monocytogenes. They demonstrated the inhibitory effects of both substances. In a study by Zhao et al.,^[@ref6]^ the amphiphilic e-poly-L-lysine (EPL)/poly (e-caprolactone) (PCL) copolymer showed a broad-spectrum antibacterial activity against *Escherichia coli*, *Staphylococcus aureus*, and *Bacillus subtilis*.

###### 

Na, K, mean PLT volume (MPV), PLT count, and PH changes in PCs inoculated with S. epidermis, *Staphylococcus aureus*, *Pseudomonas aerugenosa*, and *Escherchia coli* after the 8-day storage (PCs units with ε-PLL is compared with control PCs without ε-PLL)

  Variable                   Control PCs without ε-PLL   PCs with 50 µg/mL ε-PLL   P value   PCs with 100 µg/mL ε-PLL                 P value   PCs with 200 µg/mL ε-PLL                          P value
  -------------------------- --------------------------- ------------------------- --------- ---------------------------------------- --------- ------------------------------------------------- ---------
  *S. epidermis*                                                                                                                                                                                  
   Na                        174±1                       171±3                     0.560     172±1                                    0.698     171±2                                             0.127
   K                         3.1±0.10                    3.2±0.09                  0.555     3.5±0.12                                 0.117     3.3±0.10                                          0.542
   MPV                       10.4±0.5                    10.1±0.6                  0.860     10.2±0.4                                 0\. 310   10.2±0.7                                          0.604
   PLT count/µL              1,100,100±278,000           1,052,500±295,000         0.548     1,000,100±277,100                        0.221     990,550±292,000[\*](#t1f1){ref-type="table-fn"}   0.000
   PH                        7.2±0.10                    7.15±0.9                  0.300     7.0±0.11                                 0.530     6.99±0.15                                         0.137
  *Staphylococcus aureus*                                                                                                                                                                         
   Na                        170±2                       170±1                     0.937     171±2                                    0.824     173±1                                             0.571
   K                         3.0±0.12                    3.1±0.17                  0.598     3.3±0.13                                 0.555     3.3±0.09                                          0.435
   MPV                       9.2±0.8                     9.3±0.6                   0.369     10.0±0.8                                 0.231     9.7±0.08                                          0.381
   PLT count/µL              1,116,000±284,000           1,112,000±304,000         0.137     1,120,000±311,000                        0.119     1,013,000±321,000                                 0.150
   PH                        6.95±0.10                   7.9±0.9                   0.060     7.12±0.14                                0.204     7.07±0.10                                         0.017
  *Pseudomonas aerugenosa*                                                                                                                                                                        
   Na                        169±3                       171±2                     0.520     172±2                                    0.561     172±1                                             0.582
   K                         3.3±0.12                    3.6±0.17                  0.390     3.4±0.13                                 0.550     3.6±0.12                                          0.650
   MPV                       10.2±0.8                    10.3±0.6                  0.440     12.5±9[\*](#t1f1){ref-type="table-fn"}   0.000     8.5±0.7[\*](#t1f1){ref-type="table-fn"}           0.000
   PLT count/µL              587,000±271,000             559,000±270,000           0.29      564,000±285,000                          0.360     528,000±293,000[\*](#t1f1){ref-type="table-fn"}   0.001
   PH                        7.1±0.9                     7.0±0.11                  0.452     6.95±0.14                                0.461     7.12±0.9                                          0.344
  *Escherchia coli*                                                                                                                                                                               
   Na                        170±2                       171±1                     0.561     172±1                                    0.560     172±3                                             0.698
   K                         3.2±0.11                    3.2±0.14                  0.550     3.3±0.11                                 0.545     3.8±0.09                                          0.571
   MPV                       10.0±0.7                    10.1±0.9                  0.300     10.2±0.9                                 0.360     10.4±0.8                                          0\. 310
   PLT count/µL              1,156,000±280,000           1,153,000±280,000         0.361     1,132,000±321,000                        0.538     1,128,000±313,000                                 0.212
   PH                        7.2±0.11                    7.12±0.14                 0.460     7.15±0.11                                0.310     7.0±0.13                                          0.503

P\<0.05 were considered statistically significant. Analysis of paired t test was used to compare values

The main limitation of the present study was that the samples of each PCs were obtained on days 1, 3, 5, and 8 to determine the colony count of PCs inoculated with each bacterium. Thus, the trend of quality parameter changes was not studied. Consequently, more research on this topic is required prior to its application in clinical trials.

In conclusion, the presented data further support the proposal that ε-PLL inhibits the growth of the bacterial contaminants in room temperature stored platelets.
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